IVIG-steroids combination therapy for initial treatment of Kawasaki disease
Yoshikane, Y.; Hirose, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 522-526
2016
ISSN/ISBN: 0047-1852 PMID: 30547554 Document Number: 687166
Document emailed within 1 workday
Related Documents
Kikuta, H.; Mizuno, F.; Osato, T.; Konno, M.; Ishikawa, N.; Nanbu, H.; Anakura, M.; Oka, Y.; Matsumoto, S.; Noro, S. 1983: Development of Kawasaki disease and the initial infection by EB virus Nihon Rinsho. Japanese Journal of Clinical Medicine 41(9): 2069-2074Keren, G.; Ballin, A. 1994: New aspects of therapy in Kawasaki disease Harefuah 126(11): 667-671
Di Piero, G. 1984: Kawasaki's disease and corticosteroid therapy La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 6(2): 347-348
Kerleau, J.M.; Levesque, H.; Cailleux, N.; Héron, F.; Courtois, H.; Bourreille, J. 1994: Anticoagulant treatment in Horton's disease. a necessity during the initial phase of therapy with adrenal cortex hormones? Presse Medicale 23(25): 1181
Lucron, H.; Bosser, G.; Lethor, J.P.; Sommelet, D.; Feillet, F.; Burger, G.; Monin, P.; Marçon, F. 2004: Kawasaki disease in newborns and infants: refractory forms to immunoglobulin therapy Archives des Maladies du Coeur et des Vaisseaux 97(5): 522-528
Hwang, B.T.; Lin, C.Y.; Hsieh, K.S.; Tsuei, D.H.; Meng, C.C. 1989: High-dose intravenous gamma-globulin therapy in Kawasaki disease Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 30(1): 15-22
Wikler, M.A.; Moonsammy, G.I.; Hemsell, D.L. 1989: Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID) Journal of ChemoTherapy 1(4 Suppl): 882-883
Huppertz, H.I.; Frosch, M.; Kuhn, C.; Christen, H.J.; German, J.D.M. 1998: Treatment of juvenile dermatomyositis with high-dose oral steroids or with steroid-pulse-therapy plus low-dose oral steroids Arthritis and Rheumatism 41(9 Suppl): S264
Lebranchu, Y. 1989: Kawasaki disease. Treatment with intravenous gammaglobulins Presse Medicale 18(23): 1147-1150
Okazaki, T.; Sakatani, T.; Sasagawa, S.; Ohta, H.; Ohnishi, H.; Suzuki, K. 1987: Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease Progress in Clinical and Biological Research 250: 557-558
Beatty, G.; Hunt, P.; Smith, A.; Hoh, R.; Huang, W.; Martin, J.; Deeks, S.G. 2006: A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide Antiviral Therapy 11(3): 315-319
Kusakawa, S.; Tatara, K. 1987: Efficacies and risks of aspirin in the treatment of the Kawasaki disease Progress in Clinical and Biological Research 250: 401-413
Nakano, H. 1987: Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy Progress in Clinical and Biological Research 250: 287-297
Sangtawesin, C.; Kirawitaya, T.; Layangkool, T.; Nawasiri, W.; Vimolsarawong, N. 2003: Treatment of Kawasaki disease using locally product intravenous immunoglobulin Journal of the Medical Association of Thailand 86(Suppl 3): S656-S660
Singh, S.; Kumar, L. 1996: Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage Indian Pediatrics 33(8): 689-692
Arj-ong, S.; Chotivitayatarakorn, P.; Lertsapcharoen, P.; Khongphatthanayothin, A.; Thisyakorn, C. 2003: A cost-benefit analysis of intravenous immunoglobulin treatment in children with Kawasaki disease Journal of the Medical Association of Thailand 86(Suppl): S179-S188
Atik, E.; Foronda, A.; Bustamante, L.N.P. 2003: Kawasaki disease. Involution of giant coronary aneurysms after prolonged anti-inflammatory treatment Arquivos Brasileiros de Cardiologia 81(3): 265-272
Yamamoto, N.; Morikawa, T.; Okubo, T.; Nakada, S.; Osawa, M.; Suzuki, A. 1980: Surgical treatment of coronary aneurysm after Kawasaki's disease (mucocutaneous lymphnode syndrome, MCLS) Kyobu Geka. Japanese Journal of Thoracic Surgery 33(8): 598-602
Khokhar, N. 2002: Effectiveness of 48 weeks Interferon alfa-2b in combination with ribavirin as initial treatment of chronic hepatitis Journal of Ayub Medical College Abbottabad: Jamc 14(3): 5-8
Veen, J. 1996: Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents Nederlands Tijdschrift Voor Geneeskunde 140(44): 2164-2167